Day trip to hell: A mixed methods study of challenging psychedelic experiences
Journal of Psychedelic Studies May 27, 2021 DOI: 10.1556/2054.2021.00155 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Mixed methods study Peer reviewed |
|---|---|
| Sample size | 357 |
| Population | Participants recruited from online communities |
| Keywords | Thematic analysis Computer-assisted web interviewing Narrative Confusion Qualitative research Focus group Applied psychology |
| Citations | 53 |
| Key points | Challenging psychedelic experiences have a greater thematic range than previously identified, with confusion identified as an important aspect alongside fear. |
Abstract
Abstract Background and aims This article presents a mixed methods study of challenging psychedelic experiences or “bad trips”, with the aim of exploring the nature and characteristics of such experiences. While challenging psychedelic experiences have been studied in previous research, the article posits that the focus of this research has been overly narrow in terms of the characteristics and etiology of these experiences, and that it would be helpful to broaden our understanding of what a challenging psychedelic trip might be and how it affects users.
Methods: In the first study, respondents ( N = 38) were recruited at various online fora for individual anonymous interviews via private messaging. The Cannabis and Psychedelics User Survey used for the second study was constructed on the basis of the knowledge obtained from interviews, and recruited 319 participants (median age 33; 81% male) from seven different online communities. Respondents were asked to characterize both a typical and their worst psychedelic experience, allowing for comparisons between the two and for regression analyses of associations between challenging experiences and other factors.
Results: Both in interviews and in the survey, respondents reported a broader range of characteristics for challenging psychedelic experiences than what has previously been recognized in the research literature. Despite the often dramatic narratives, they were convinced that the experience had positive long-term consequences.
Conclusions: The two studies found that challenging psychedelic experiences have a greater thematic range than what has previously been identified. Besides the near ubiquity of fear in these experiences, confusion was also identified as an important aspect. Meditation practice had paradoxical effects on challenging psychedelic experiences, appearing as a fruitful area for further research.
Citations in the library
Cited by 52
- Extended difficulties following the use of psychedelic drugs: A mixed methods study PLoS One October 24, 2023
- Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. Journal of Psychopharmacology January 5, 2022
- Case analysis of long-term negative psychological responses to psychedelics Scientific Reports September 25, 2023
- Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands Journal of Psychedelic Studies January 16, 2023
- Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences Scientific Reports August 22, 2023
and 47 more in the library
Cites 32
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
and 27 more in the library